Found: 13
Select item for more details and to access through your institution.
Switching to a rilpivirine/emtricitabine/tenofovir single-tablet regimen in RNA-suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96 weeks.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.915578
- By:
- Publication type:
- Article
The Characteristics and Functionalities of Mobile Apps Aimed at Patients Diagnosed With Immune-Mediated Inflammatory Diseases: Systematic App Search.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e861, doi. 10.1634/theoncologist.2019-0031
- By:
- Publication type:
- Article
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey.
- Published in:
- Journal of Medical Internet Research, 2022, v. 24, n. 9, p. N.PAG, doi. 10.2196/37445
- By:
- Publication type:
- Article
Dolutegravir-Based Dual Therapies in HIV Pretreated Patients: A Real-Life Study in Madrid.
- Published in:
- Annals of Pharmacotherapy, 2022, v. 56, n. 4, p. 401, doi. 10.1177/10600280211038504
- By:
- Publication type:
- Article
Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/Lamivudine Single-Tablet Regimen in a Real-Life Cohort of HIV-1 Adult Infected Patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Effectiveness, Safety, and Costs of a Treatment Switch to Dolutegravir Plus Rilpivirine Dual Therapy in Treatment-Experienced HIV Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of the hospital care quality perceived by patients with immune‐mediated inflammatory diseases from the pharmacy service. SACVINFA study.
- Published in:
- Journal of Clinical Pharmacy & Therapeutics, 2022, v. 47, n. 12, p. 2020, doi. 10.1111/jcpt.13742
- By:
- Publication type:
- Article
Implantación y evaluación de un modelo de atención farmacéutica domiciliaria mediante Telefarmacia.
- Published in:
- Farmacia Hospitalaria (1130-6343), 2022, v. 46, p. 36, doi. 10.7399/fh.13252
- By:
- Publication type:
- Article
Utility of 1,3 β-d-Glucan Assay for Guidance in Antifungal Stewardship Programs for Oncologic Patients and Solid Organ Transplant Recipients.
- Published in:
- Journal of Fungi, 2021, v. 7, n. 1, p. 1, doi. 10.3390/jof7010059
- By:
- Publication type:
- Article